Medical condition
Relapsed Or Refractory Multiple Myeloma
Relapsed Or Refractory Multiple Myeloma is a medical condition tracked by NovaPharmaNews across 2 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- linvoseltamab (LYNOZYFIC) Antineoplastic and immunomodulating agents (L01)
- belantamab mafodotin (BLENREP) Antineoplastic and immunomodulating agents (L01)